Clinical Trial Update: Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HAD induction with intensified cytarabine in newly diagnosed CEBPA double-mutated acute myeloid leukemia; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Homoharringtonine (homoharringtonine)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: CEBPA Double Mutation, Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING